Evidence map›Paper›PMID 35628625›Full record

ArticleInternational journal of molecular sciences2022

Nanosheets Based Approach to Elevate the Proliferative and Differentiation Efficacy of Human Wharton's Jelly Mesenchymal Stem Cells.

Suraj Kumar Singh, Anshuman Singh, Vinod Kumar, Jalaj Gupta, Sima Umrao, Manoj Kumar, Devojit Kumar Sarma, Marcis Leja, Manohar Prasad Bhandari, Vinod Verma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Suraj Kumar SinghStem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow 226014, India.ORCID 0000-0003-4893-2408
Anshuman SinghStem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow 226014, India.
Vinod KumarStem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow 226014, India.
Jalaj GuptaStem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow 226014, India.
Sima UmraoIndian Institute of Science (IISC), Bangalore 560012, India.ORCID 0000-0001-8438-0626
Manoj KumarICMR-National Institute for Research in Environmental Health, Bhopal 462030, India.ORCID 0000-0002-2040-8631
Devojit Kumar SarmaICMR-National Institute for Research in Environmental Health, Bhopal 462030, India.ORCID 0000-0002-2749-4114
Marcis LejaInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-0319-8855
Manohar Prasad BhandariInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0003-2712-476X
Vinod VermaStem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow 226014, India.

Funding

Science and Engineering Research Board CRG/2018/000131
6 · The paper itself

Abstract

Mesenchymal stem cell (MSC)-based therapy and tissue repair necessitate the use of an ideal clinical biomaterial capable of increasing cell proliferation and differentiation. Recently, MXenes 2D nanomaterials have shown remarkable potential for improving the functional properties of MSCs. In the present study, we elucidated the potential of Ti

Indexed as

Mesenchymal Stem CellsWharton JellyBiocompatible MaterialsCell DifferentiationHumansImmunologic FactorsBiocompatible MaterialsImmunologic Factorscell differentiationcell proliferationcell viabilityhWJ-MSCsnanosheetsstemnessTi2CTx MXene

Identifiers

PMID35628625
PMCPMC9143505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.